Cargando…
Migraine in Patients Undergoing PFO Closure: Characterization of a Platelet-Associated Pathophysiological Mechanism: The LEARNER Study
The association between migraine and patent foramen ovale (PFO) has been documented. We aimed to investigate platelet activation, prothrombotic phenotype, and oxidative stress status of migraineurs with PFO on 100 mg/day aspirin, before and 6 months after PFO closure. Data show that, before PFO clos...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270571/ https://www.ncbi.nlm.nih.gov/pubmed/35818509 http://dx.doi.org/10.1016/j.jacbts.2022.02.002 |
_version_ | 1784744493044465664 |
---|---|
author | Trabattoni, Daniela Brambilla, Marta Canzano, Paola Becchetti, Alessia Teruzzi, Giovanni Porro, Benedetta Fiorelli, Susanna Muratori, Manuela Tedesco, Calogero C. Veglia, Fabrizio Montorsi, Piero Bartorelli, Antonio L. Tremoli, Elena Camera, Marina |
author_facet | Trabattoni, Daniela Brambilla, Marta Canzano, Paola Becchetti, Alessia Teruzzi, Giovanni Porro, Benedetta Fiorelli, Susanna Muratori, Manuela Tedesco, Calogero C. Veglia, Fabrizio Montorsi, Piero Bartorelli, Antonio L. Tremoli, Elena Camera, Marina |
author_sort | Trabattoni, Daniela |
collection | PubMed |
description | The association between migraine and patent foramen ovale (PFO) has been documented. We aimed to investigate platelet activation, prothrombotic phenotype, and oxidative stress status of migraineurs with PFO on 100 mg/day aspirin, before and 6 months after PFO closure. Data show that, before PFO closure, expression of the classical platelet activation markers is comparable in patients and aspirin-treated healthy subjects. Conversely, MHA-PFO patients display an increased prothrombotic phenotype (higher tissue factor(pos) platelets and microvesicles and thrombin-generation potential), sustained by an altered oxidative stress status. This phenotype, which is more controlled by P2Y(12)-blockade than by aspirin, reverted after PFO closure together with a complete migraine remission. (pLatelEts And MigRaine iN patEnt foRamen Ovale [LEARNER]; NCT03521193) |
format | Online Article Text |
id | pubmed-9270571 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-92705712022-07-10 Migraine in Patients Undergoing PFO Closure: Characterization of a Platelet-Associated Pathophysiological Mechanism: The LEARNER Study Trabattoni, Daniela Brambilla, Marta Canzano, Paola Becchetti, Alessia Teruzzi, Giovanni Porro, Benedetta Fiorelli, Susanna Muratori, Manuela Tedesco, Calogero C. Veglia, Fabrizio Montorsi, Piero Bartorelli, Antonio L. Tremoli, Elena Camera, Marina JACC Basic Transl Sci Clinical Research The association between migraine and patent foramen ovale (PFO) has been documented. We aimed to investigate platelet activation, prothrombotic phenotype, and oxidative stress status of migraineurs with PFO on 100 mg/day aspirin, before and 6 months after PFO closure. Data show that, before PFO closure, expression of the classical platelet activation markers is comparable in patients and aspirin-treated healthy subjects. Conversely, MHA-PFO patients display an increased prothrombotic phenotype (higher tissue factor(pos) platelets and microvesicles and thrombin-generation potential), sustained by an altered oxidative stress status. This phenotype, which is more controlled by P2Y(12)-blockade than by aspirin, reverted after PFO closure together with a complete migraine remission. (pLatelEts And MigRaine iN patEnt foRamen Ovale [LEARNER]; NCT03521193) Elsevier 2022-04-13 /pmc/articles/PMC9270571/ /pubmed/35818509 http://dx.doi.org/10.1016/j.jacbts.2022.02.002 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Clinical Research Trabattoni, Daniela Brambilla, Marta Canzano, Paola Becchetti, Alessia Teruzzi, Giovanni Porro, Benedetta Fiorelli, Susanna Muratori, Manuela Tedesco, Calogero C. Veglia, Fabrizio Montorsi, Piero Bartorelli, Antonio L. Tremoli, Elena Camera, Marina Migraine in Patients Undergoing PFO Closure: Characterization of a Platelet-Associated Pathophysiological Mechanism: The LEARNER Study |
title | Migraine in Patients Undergoing PFO Closure: Characterization of a Platelet-Associated Pathophysiological Mechanism: The LEARNER Study |
title_full | Migraine in Patients Undergoing PFO Closure: Characterization of a Platelet-Associated Pathophysiological Mechanism: The LEARNER Study |
title_fullStr | Migraine in Patients Undergoing PFO Closure: Characterization of a Platelet-Associated Pathophysiological Mechanism: The LEARNER Study |
title_full_unstemmed | Migraine in Patients Undergoing PFO Closure: Characterization of a Platelet-Associated Pathophysiological Mechanism: The LEARNER Study |
title_short | Migraine in Patients Undergoing PFO Closure: Characterization of a Platelet-Associated Pathophysiological Mechanism: The LEARNER Study |
title_sort | migraine in patients undergoing pfo closure: characterization of a platelet-associated pathophysiological mechanism: the learner study |
topic | Clinical Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270571/ https://www.ncbi.nlm.nih.gov/pubmed/35818509 http://dx.doi.org/10.1016/j.jacbts.2022.02.002 |
work_keys_str_mv | AT trabattonidaniela migraineinpatientsundergoingpfoclosurecharacterizationofaplateletassociatedpathophysiologicalmechanismthelearnerstudy AT brambillamarta migraineinpatientsundergoingpfoclosurecharacterizationofaplateletassociatedpathophysiologicalmechanismthelearnerstudy AT canzanopaola migraineinpatientsundergoingpfoclosurecharacterizationofaplateletassociatedpathophysiologicalmechanismthelearnerstudy AT becchettialessia migraineinpatientsundergoingpfoclosurecharacterizationofaplateletassociatedpathophysiologicalmechanismthelearnerstudy AT teruzzigiovanni migraineinpatientsundergoingpfoclosurecharacterizationofaplateletassociatedpathophysiologicalmechanismthelearnerstudy AT porrobenedetta migraineinpatientsundergoingpfoclosurecharacterizationofaplateletassociatedpathophysiologicalmechanismthelearnerstudy AT fiorellisusanna migraineinpatientsundergoingpfoclosurecharacterizationofaplateletassociatedpathophysiologicalmechanismthelearnerstudy AT muratorimanuela migraineinpatientsundergoingpfoclosurecharacterizationofaplateletassociatedpathophysiologicalmechanismthelearnerstudy AT tedescocalogeroc migraineinpatientsundergoingpfoclosurecharacterizationofaplateletassociatedpathophysiologicalmechanismthelearnerstudy AT vegliafabrizio migraineinpatientsundergoingpfoclosurecharacterizationofaplateletassociatedpathophysiologicalmechanismthelearnerstudy AT montorsipiero migraineinpatientsundergoingpfoclosurecharacterizationofaplateletassociatedpathophysiologicalmechanismthelearnerstudy AT bartorelliantoniol migraineinpatientsundergoingpfoclosurecharacterizationofaplateletassociatedpathophysiologicalmechanismthelearnerstudy AT tremolielena migraineinpatientsundergoingpfoclosurecharacterizationofaplateletassociatedpathophysiologicalmechanismthelearnerstudy AT cameramarina migraineinpatientsundergoingpfoclosurecharacterizationofaplateletassociatedpathophysiologicalmechanismthelearnerstudy |